Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers

scientific article published on 18 September 2018

Bioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CLINTHERA.2018.08.009
P698PubMed publication ID30241688

P2093author name stringXia Chen
Yongjun Wang
Yilong Wang
Xingquan Zhao
Weiwei Zhao
Jiaqing Wang
Weicong Wang
Pengpeng Zhao
Chunmin Xu
Baoshi Yuan
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectedaravoneQ335099
bioavailabilityQ461809
P304page(s)1683-1691
P577publication date2018-09-18
P1433published inClinical TherapeuticsQ15716601
P1476titleBioavailability of Edaravone Sublingual Tablet Versus Intravenous Infusion in Healthy Male Volunteers
P478volume40

Reverse relations

cites work (P2860)
Q96434774A Randomized, Single-Blind, Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects
Q97542076Experimental and theoretical study on structure-tautomerism among edaravone, isoxazolone, and their heterocycles derivatives as antioxidants
Q90348962Synthesis, Characterization, and In Vivo Evaluation of Desmethyl Anethole Trithione Phosphate Prodrug for Ameliorating Cerebral Ischemia-Reperfusion Injury in Rats